Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 4/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 2/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.75 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11559506 | 0.94 | OPRM1 (0.88) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11565724 | 0.94 | OPRM1 (0.88) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11798037 | 0.93 | OPRM1 (0.86) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11564673 | 0.93 | OPRM1 (0.86) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11566771 | 0.93 | OPRM1 (0.86) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11569060 | 0.92 | OPRM1 (0.84) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11565395 | 0.91 | OPRM1 (0.84) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11568358 | 0.90 | OPRM1 (0.82) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11569132 | 0.90 | OPRM1 (0.80) | OPRM1OPRD1OPRK1SLC22A1ABCB1 | |
| SCHEMBL11565063 | 0.89 | OPRM1 (0.81) | OPRM1OPRD1OPRK1SLC22A1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3998834-A | ANALGESICS | JANSSEN PHARMACEUTICA N.V. (BE) | 1976-12-21 | — | — | US | claimed |
| US-20260060822-A1 | BIOENGINEERED SCAFFOLDS FOR VASCULAR GRAFTS AND METHODS OF USE THEREOF | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2026-03-05 | — | — | US | disclosed |
| US-12529695-B2 | Fentanyl analogue detection methods and kits thereof | VERITEQUE USA, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20250366979-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | METHODIST HOSPITAL (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250366978-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | METHODIST HOSPITAL (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250251323-A1 | COLLECTION PROBE AND METHODS OF USE THEREOF | BAYLOR COLLEGE OF MEDICINE | 2025-08-07 | — | — | US | disclosed |
| WO-2025128946-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | THE METHODIST HOSPITAL (US) | 2025-06-19 | — | — | WO | disclosed |
| EP-4536138-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | The Methodist Hospital (US) | 2025-04-16 | — | — | EP | disclosed |
| EP-4536139-A1 | DEVICES AND METHODS OF MAKING AND USE THEREOF | The Methodist Hospital (US) | 2025-04-16 | — | — | EP | disclosed |
| EP-4507825-A1 | COLLECTION PROBE AND METHODS OF USE THEREOF | Board of Regents, The University of Texas System (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20220390439-A1 | FENTANYL ANALOGUE DETECTION METHODS AND KITS THEREOF | VERITEQUE USA, INC. | 2022-12-08 | — | — | US | disclosed |
| US-20220226446-A1 | NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION | BONTI INC (US) | 2022-07-21 | — | — | US | disclosed |
| US-20210093557-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | ADAPT PHARMA LTD (IE) | 2021-04-01 | — | — | US | disclosed |
| US-20200352917-A1 | MEDICATED SPRAY FOR TREATMENT OF SUBSTANCE ABUSE, OVERDOSE, ADDICTION AND IMPULSE CONTROL DISORDERS | GOOBERMAN LANCE L (US) | 2020-11-12 | — | — | US | disclosed |
| US-20200030229-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | Adapt Pharma Limited | 2020-01-30 | — | — | US | disclosed |
| US-20190015323-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | Adaph Pharma Limited | 2019-01-17 | — | — | US | disclosed |
| US-20170071851-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | INDIVIOR UK LIMITED (GB) | 2017-03-16 | — | — | US | disclosed |
| US-20170071851-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | INDIVIOR UK LIMITED (GB) | 2017-03-16 | — | — | US | disclosed |
| US-4179569-A | ANALGESIC INTERMEDIATES | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-12-18 | — | — | US | disclosed |
| US-3998834-A | ANALGESICS | JANSSEN PHARMACEUTICA N.V. (BE) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170071851-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | OPRL1, OPRM1, OPRK1 | OPRM1 2/4885OPRD1 4/4885OPRK1 3/4885 |
| US-20210093557-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | OPRL1, OPRM1, OPRK1 | OPRM1 2/4885OPRD1 4/4885OPRK1 3/4885 |
| US-12529695-B2 | Fentanyl analogue detection methods and kits thereof | CA13, CA2, CA12 | OPRM1 24/4885OPRD1 6/4885OPRK1 19/4885 |
| US-20260060822-A1 | BIOENGINEERED SCAFFOLDS FOR VASCULAR GRAFTS AND METHODS OF USE THEREOF | PFKP, PBK, MYLK | OPRM1 4810/4885OPRD1 4518/4885OPRK1 2862/4885 |
| US-20190015323-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | OPRL1, OPRM1, OPRK1 | OPRM1 2/4885OPRD1 4/4885OPRK1 3/4885 |
| US-20200030229-A1 | NASAL DRUG PRODUCTS AND METHODS OF THEIR USE | OPRL1, OPRM1, OPRK1 | OPRM1 2/4885OPRD1 4/4885OPRK1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.